[P28] Poster Session 28　Lung Cancer/Thoracic Cancer（EGFR TKI）

[P28-2] Prognostic markers among patients with ALK-positive non-small cell lung cancer receiving first-line alectinib

^○Takayuki Takeda¹, Tadaaki Yamada², Keiko Tanimura¹, Takayuki Nakano¹, Masaki Ishida², Yusuke Tachibana³, Shinsuke Shiotsu³, Shigeto Horiuchi⁴, Makoto Hibino⁴, Asuka Okada⁵, Yusuke Chihara⁶, Koichi Takayama² (1.Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, 2.Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 3.Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, 4.Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, 5.Department of Respiratory Medicine, Saiseikai Suita Hospital, 6.Department of Respiratory Medicine, Uji-Tokushukai Medical Center)